Disease

Recurrent diabetic ketoacidosis is associated with substantial mortality, particularly among young

Rafiuzzaman Sifat - Jul 19, 2016

News Hour: A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes ) shows that recurrent episodes of diabetic ketoacidosis (DKA) ‒ a potentially life-threatening condition brought on by...
AIDS 2016 focuses on impact of legal and policy barriers to HIV services for groups at greatest risk of infection

Rafiuzzaman Sifat - Jul 19, 2016

News Hour: In an official press conference at the 21stInternational AIDS Conference (AIDS 2016) in Durban, researchers and community representatives discussed the impact of discriminatory laws and policies in many parts of the world that hinder...
Austrian biotech plans Zika vaccine clinical trials in 12 months

Rafiuzzaman Sifat - Jul 13, 2016

News Hour: An Austrian biotech company working with the Institut Pasteur said on Tuesday it planned to start clinical trials with an experimental Zika vaccine in the next 12 months, marking a further acceleration of research...
AIDS conference returns to a changed South Africa

Rafiuzzaman Sifat - Jul 13, 2016

News Hour: The South Africa that hosts a global AIDS Conference next week has come a long way from the “AIDS pariah” that did so 16 years ago, when then President Thabo Mbeki stunningly dismissed the...
Ultragenyx and takeda enter into a collaboration to develop and commercialize therapies for rare genetic diseases

Rafiuzzaman Sifat - Jul 12, 2016

News Hour: Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare genetic diseases, and Takeda Pharmaceutical Company Limited, announced a strategic partnership to develop and commercialize...
Juno cancer study halted after patient deaths, shares slide 30 pct

Rafiuzzaman Sifat - Jul 10, 2016

News Hour: A Juno Therapeutics Inc trial of its experimental cancer therapy, known as JCAR015, was put on hold by U.S. regulators after the deaths last week of two leukemia patients, the company said on Thursday....
Low heart risk in middle age tied to less disability in later years

Rafiuzzaman Sifat - Jul 10, 2016

News Hour: People with few or no heart disease risk factors when they’re in their 40s are less likely to have trouble with activities of daily living in old age, a recent study suggests. Some of...
European commission approves trevicta® (paliperidone palmitate a 3-monthly injection), for maintenance treatment of schizophrenia

Rafiuzzaman Sifat - Jul 9, 2016

News Hour: Janssen-Cilag International NV announced that the European Commission (EC) has approved the use of TREVICTA® (paliperidone palmitate a 3-monthly injection) for the maintenance treatment of schizophrenia in adult patients. TREVICTA will provide the longest...
New idylla™ ebola virus triage test granted emergency use authorization by u.s. fda

Rafiuzzaman Sifat - Jul 8, 2016

News Hour: As part of Johnson & Johnson’s commitment to combat Ebola, Janssen Pharmaceutica NV announced that the Idylla™ Ebola Virus Triage Test (Idylla™ EBOV Test) was granted Emergency Use Authorization (EUA) by the U.S. Food...
Anthem Blue Cross of California and VRA implement new rates for Breast Cancer patients

Mehrab Masayeed Habib - Jul 7, 2016

News Hour: Anthem Blue Cross of California and Valley Radiotherapy Associates Medical Group (VRA) have developed a new agreement for a single episode-of-care payment for patients with a breast cancer diagnosis requiring radiation therapy treatment. The case...

« Previous 1 … 68 69 70 71 Next »

Disease

Recurrent diabetic ketoacidosis is associated with substantial mortality, particularly among young

AIDS 2016 focuses on impact of legal and policy barriers to HIV services for groups at greatest risk of infection

Austrian biotech plans Zika vaccine clinical trials in 12 months

AIDS conference returns to a changed South Africa

Ultragenyx and takeda enter into a collaboration to develop and commercialize therapies for rare genetic diseases

Juno cancer study halted after patient deaths, shares slide 30 pct

Low heart risk in middle age tied to less disability in later years

European commission approves trevicta® (paliperidone palmitate a 3-monthly injection), for maintenance treatment of schizophrenia

New idylla™ ebola virus triage test granted emergency use authorization by u.s. fda

Anthem Blue Cross of California and VRA implement new rates for Breast Cancer patients

Facebook

Twitter